68070 Federal Register / Vol. 70, No. 216 / Wednesday, November 9, 2005 / Notices 

including the charter, roster, and 

records of past meetings can be found at 

http://ntp.niehs.nih.gov/ see ‘‘Advisory 

Board & Committees.’’ Information 

about NICEATM and ICCVAM activities 

can be found at the NICEATM/ICCVAM 

Web site (http://iccvam.niehs.nih.gov) 

or by contacting the Director of 

NICEATM, Dr. William Stokes 

(telephone: 919–541–2384, or E-mail: 

niceatm@niehs.nih.gov).

Dated: October 26, 2005. 

Samuel H. Wilson, 

Deputy Director, National Institute of 

Environmental Health Sciences.

[FR Doc. 05–22320 Filed 11–8–05; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: Cleaning Mucus From 

Endotracheal Tubes

AGENCY: National Institutes of Health, 

Public Health Service, HHS.

ACTION: Notice.

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

404.7(a)(1)(i), that the National 

Institutes of Health (NIH), Department 

of Health and Human Services, is 

contemplating the grant of an exclusive 

worldwide license to practice the 

invention embodied in E–061–2004/0, 

‘‘Mucus Shaving Apparatus for 

Endotracheal Tubes’’ (Patent 

Application Ser. No. 10/773,570 filed 

February 5, 2004), and E–061–2004/1, 

‘‘Mucus Shaving Apparatus for 

Endotracheal Tubes with Bacteriocidal 

Properties’’ (International Patent 

Application PCT/US2005/003395 filed 

February 5, 2005), to C.R. Bard, Inc., a 

New Jersey corporation having its 

headquarters in Murray Hill, New Jersey 

and a division, Bard Medical Division, 

having offices in Covington, GA. The 

United States of America is the assignee 

of the patent rights of the above 

invention. 

The contemplated exclusive license 

may be granted in the field of cleaning 

mucus deposits from endotracheal 

tubes.

DATES: Only written comments and/or 

applications for a license received by 

the NIH Office of Technology Transfer 

on or before January 9, 2006 will be 

considered.

ADDRESSES: Requests for a copy of the 

patent application, inquiries, comments 

and other materials relating to the 

contemplated license should be directed 

to: Michael A. Shmilovich, Esq., Office 

of Technology Transfer, National 

Institutes of Health, 6011 Executive 

Boulevard, Suite 325, Rockville, MD 

20852–3804; Telephone: (301) 435–

5019; Facsimile: (301) 402–0220; E-mail: 

shmilovm@mail.nih.gov. A signed 

confidentiality nondisclosure agreement 

will be required to receive copies of the 

patent applications.

SUPPLEMENTARY INFORMATION: The patent 

applications intended for licensure 

disclose and/or cover the following: E–

061–2004/0, ‘‘Mucus Shaving Apparatus 

for Endotracheal Tubes,’’ and E–061–

2004/1, ‘‘Mucus Shaving Apparatus for 

Endotracheal Tubes with Bactericidal 

Properties.’’

This invention is an endotracheal 

tube cleaning apparatus for insertion 

into the inside of the endotracheal tube 

of a patient to shave away mucus 

deposits. This cleaning apparatus 

comprises a flexible central tube with an 

inflatable balloon at its distal end. 

Affixed to the inflatable balloon are one 

or more shaving rings, each having a 

squared leading edge to shave away 

mucus accumulations implicated in 

bacterial accumulation. In operation, the 

un-inflated cleaning apparatus is 

inserted into the endotracheal tube until 

its distal end is properly aligned with 

the distal end of the endotracheal tube. 

After proper alignment, the balloon is 

inflated by a suitable inflation device 

(e.g., a syringe) until the balloon’s 

shaving rings are pressed against the 

inside surface of the endotracheal tube. 

The cleaning apparatus is then pulled 

out of the endotracheal tube and in the 

process the balloon’s shaving rings 

shave off the mucus deposits from the 

inside of the endotracheal tube. 

The prospective exclusive license will 

be royalty bearing and will comply with 

the terms and conditions of 35 U.S.C. 

209 and 37 CFR 404.7. The prospective 

exclusive license may be granted unless, 

within sixty (60) days from the date of 

this published notice, NIH receives 

written evidence and argument that 

establishes that the grant of the license 

would not be consistent with the 

requirements of 35 U.S.C. 209 and 37 

CFR 404.7. 

Properly filed competing applications 

for a license filed in response to this 

notice will be treated as objections to 

the contemplated license. Comments 

and objections submitted in response to 

this notice will not be made available 

for public inspection, and, to the extent 

permitted by law, will not be released 

under the Freedom of Information Act, 

5 U.S.C. 552.

Dated: October 31, 2005. 

Steven M. Ferguson, 

Director, Division of Technology Development 

and Transfer, Office of Technology Transfer, 

National Institutes of Health.

[FR Doc. 05–22319 Filed 11–8–05; 8:45 am]

BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

Open Meeting of the Federal 

Interagency Committee on Emergency 

Medical Services (FICEMS)

AGENCY: Federal Emergency 

Management Agency (FEMA), 

Department of Homeland Security.

ACTION: Notice of open meeting.

SUMMARY: FEMA announces the 

following open meeting. 

Name: Federal Interagency Committee 

on Emergency Medical Services 

(FICEMS). 

Date of Meeting: December 1, 2005. 

Place: 3rd Floor Conference Center, 

Potomac Room, Parklawn Building, 

5600 Fishers Lane Rockville, Maryland 

20857. 

Times: 10:30 a.m.—Main FICEMS 

Meeting; 1 p.m.—FICEMS Ambulance 

Safety Subcommittee. 

Proposed Agenda: Review and 

submission for approval of previous 

FICEMS Committee Meeting Minutes; 

Ambulance Safety Subcommittee and 

Counter-terrorism Subcommittee report; 

Action Items review; presentation of 

member agency reports; and reports of 

other interested parties.

SUPPLEMENTARY INFORMATION: This 

meeting will be open to the public with 

limited seating available on a first-come, 

first-served basis. See the Response and 

Security Procedures below. For those 

driving, parking is $7.00 per day. 

Response Procedures: Committee 

Members and members of the general 

public who plan to attend the meeting 

should contact Mr. Mike McKay, on or 

before Tuesday, November 29, 2005, via 

mail at NATEK Incorporated, 21355 

Ridgetop Circle, Suite 200, Dulles, 

Virginia 20166–8503, or by telephone at 

(703) 674–0190, or via facsimile at (703) 

674–0195, or via e-mail at 

mmckay@natekinc.com. This is 

necessary to be able to create and 

provide a current roster of visitors to 

HRSA Security per directives. 

Security Procedures: Increased 

security controls and surveillance are in 

effect at the Parklawn Building/HRSA 

facilities. All visitors must have a valid